BIT
IOVA icon

BlackRock Institutional Trust’s Iovance Biotherapeutics IOVA Stock Holding History

BlackRock Institutional Trust’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.81M Buy
1,268,264
+41,240
+3% +$284K ﹤0.01% 2465
2016
Q3 		$10.1M Buy
1,227,024
+85,823
+8% +$726K ﹤0.01% 2326
2016
Q2 		$9.24M Buy
1,141,201
+14,415
+1% +$90.5K ﹤0.01% 2334
2016
Q1 		$5.72M Sell
1,126,786
-3,719
-0.3% -$20.4K ﹤0.01% 2588
2015
Q4 		$8.73M Buy
1,130,505
+54,526
+5% +$378K ﹤0.01% 2414
2015
Q3 		$6.2M Buy
1,075,979
+37,936
+4% +$295K ﹤0.01% 2596
2015
Q2 		$9.52M Buy
1,038,043
+895,736
+629% +$10M ﹤0.01% 2438
2015
Q1 		$1.72M Buy
+142,307
New +$1.6M ﹤0.01% 3178

Other funds holding IOVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return